![logo](/logos/AJANTPHARM.NS.webp)
Ajanta Pharma Limited
NSE:AJANTPHARM.NS
3,350.35 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ajanta Pharma Limited |
Symbool | AJANTPHARM.NS |
Munteenheid | INR |
Prijs | 3,350.35 |
Beurswaarde | 418,498,919,200 |
Dividendpercentage | 1.71% |
52-weken bereik | 1,650.05 - 3,409.4 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yogesh Mannalal Agrawal M.B.A |
Website | https://www.ajantapharma.com |
An error occurred while fetching data.
Over Ajanta Pharma Limited
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)